These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 27697528)
1. Doxorubicin-induced epithelial-mesenchymal transition through SEMA 4A in hepatocellular carcinoma. Pan JX; Wang F; Ye LY Biochem Biophys Res Commun; 2016 Oct; 479(4):610-614. PubMed ID: 27697528 [TBL] [Abstract][Full Text] [Related]
2. ARK5 promotes doxorubicin resistance in hepatocellular carcinoma via epithelial-mesenchymal transition. Xu T; Zhang J; Chen W; Pan S; Zhi X; Wen L; Zhou Y; Chen BW; Qiu J; Zhang Y; Yang Q; Feng X; Bai X; Liang T Cancer Lett; 2016 Jul; 377(2):140-8. PubMed ID: 27126361 [TBL] [Abstract][Full Text] [Related]
3. FBW7 increases chemosensitivity in hepatocellular carcinoma cells through suppression of epithelial-mesenchymal transition. Yu J; Zhang W; Gao F; Liu YX; Chen ZY; Cheng LY; Xie SF; Zheng SS Hepatobiliary Pancreat Dis Int; 2014 Apr; 13(2):184-91. PubMed ID: 24686546 [TBL] [Abstract][Full Text] [Related]
4. Cx32 reverses epithelial-mesenchymal transition in doxorubicin-resistant hepatocellular carcinoma. Yu M; Han G; Qi B; Wu X Oncol Rep; 2017 Apr; 37(4):2121-2128. PubMed ID: 28260043 [TBL] [Abstract][Full Text] [Related]
5. ZEB1 mediates doxorubicin (Dox) resistance and mesenchymal characteristics of hepatocarcinoma cells. Long L; Xiang H; Liu J; Zhang Z; Sun L Exp Mol Pathol; 2019 Feb; 106():116-122. PubMed ID: 30615851 [TBL] [Abstract][Full Text] [Related]
6. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092 [TBL] [Abstract][Full Text] [Related]
7. NSC 74859 enhances doxorubicin cytotoxicity via inhibition of epithelial-mesenchymal transition in hepatocellular carcinoma cells. Hu QD; Chen W; Yan TL; Ma T; Chen CL; Liang C; Zhang Q; Xia XF; Liu H; Zhi X; Zheng XX; Bai XL; Yu XZ; Liang TB Cancer Lett; 2012 Dec; 325(2):207-13. PubMed ID: 22781398 [TBL] [Abstract][Full Text] [Related]
8. miR-145 regulates chemoresistance in hepatocellular carcinoma via epithelial mesenchymal transition. Ju BL; Chen YB; Zhang WY; Yu CH; Zhu DQ; Jin J Cell Mol Biol (Noisy-le-grand); 2015 May; 61(3):12-6. PubMed ID: 26068913 [TBL] [Abstract][Full Text] [Related]
9. Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma. Ma Z; Guo D; Wang Q; Liu P; Xiao Y; Wu P; Wang Y; Chen B; Liu Z; Liu Q Theranostics; 2019; 9(10):2967-2983. PubMed ID: 31244936 [TBL] [Abstract][Full Text] [Related]
10. FOXF2 deficiency promotes hepatocellular carcinoma metastasis by inducing mesenchymal-epithelial transition. Dou C; Jin X; Sun L; Zhang B; Han M; Li T Cancer Biomark; 2017 Jul; 19(4):447-454. PubMed ID: 28582850 [TBL] [Abstract][Full Text] [Related]
11. The role of CD29-ILK-Akt signaling-mediated epithelial-mesenchymal transition of liver epithelial cells and chemoresistance and radioresistance in hepatocellular carcinoma cells. Jiang X; Wang J; Zhang K; Tang S; Ren C; Chen Y Med Oncol; 2015 May; 32(5):141. PubMed ID: 25805567 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus x protein induces epithelial-mesenchymal transition of hepatocellular carcinoma cells by regulating long non-coding RNA. Jin Y; Wu D; Yang W; Weng M; Li Y; Wang X; Zhang X; Jin X; Wang T Virol J; 2017 Dec; 14(1):238. PubMed ID: 29258558 [TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells. Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164 [TBL] [Abstract][Full Text] [Related]
14. ECM1 promotes migration and invasion of hepatocellular carcinoma by inducing epithelial-mesenchymal transition. Chen H; Jia W; Li J World J Surg Oncol; 2016 Jul; 14(1):195. PubMed ID: 27460906 [TBL] [Abstract][Full Text] [Related]
16. Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma. Dai X; Ahn KS; Wang LZ; Kim C; Deivasigamni A; Arfuso F; Um JY; Kumar AP; Chang YC; Kumar D; Kundu GC; Magae J; Goh BC; Hui KM; Sethi G Mol Cancer Ther; 2016 Dec; 15(12):2966-2976. PubMed ID: 27765853 [TBL] [Abstract][Full Text] [Related]
17. Fascin-1 expression correlates with repression of E-cadherin expression in hepatocellular carcinoma cells and augments their invasiveness in combination with matrix metalloproteinases. Hayashi Y; Osanai M; Lee GH Cancer Sci; 2011 Jun; 102(6):1228-35. PubMed ID: 21323792 [TBL] [Abstract][Full Text] [Related]
18. linc‑ROR facilitates hepatocellular carcinoma resistance to doxorubicin by regulating TWIST1‑mediated epithelial‑mesenchymal transition. Zhang Y; Wu W; Sun Q; Ye L; Zhou D; Wang W Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760121 [TBL] [Abstract][Full Text] [Related]
19. PEG10 is imperative for TGF-β1-induced epithelial‑mesenchymal transition in hepatocellular carcinoma. Zhang M; Sui C; Dai B; Shen W; Lu J; Yang J Oncol Rep; 2017 Jan; 37(1):510-518. PubMed ID: 28004118 [TBL] [Abstract][Full Text] [Related]
20. CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma. Huang D; Cao L; Zheng S J Exp Clin Cancer Res; 2017 Jan; 36(1):13. PubMed ID: 28093067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]